Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Burak Ozbay

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Clinical Therapeutics|October 25, 2011
Risk factors for hypoglycemia-related hospitalization in patients with type 2 diabetes: a nested case-control studyBrian J Quilliam, Jason C Simeone, A Burak Ozbay
The American Journal of Managed Care|November 23, 2011
The incidence and costs of hypoglycemia in type 2 diabetesBrian J Quilliam, Jason C Simeone, A Burak Ozbay, et al.
Current Medical Research and Opinion|June 9, 2025
Improving CRC screening in an underserved population: real-world adherence to mt-sDNA testing among the incarcerated in Nebraska, United StatesMallik Greene, Timo Pew, A Burak Ozbay, et al.
The American Journal of Gastroenterology|December 14, 2019
Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare PatientsStuart C Gordon, Jeremy Fraysse, Suying Li, et al.
Current Medical Research and Opinion|March 3, 2025
Adherence to mt-sDNA testing for colorectal cancer screening among new users in a US Black populationMallik Greene, Shrey Gohil, Mark Camardo, et al.
Current Medical Research and Opinion|January 21, 2021
Recent trends in colorectal cancer screening methods based on Medicare claims dataPaul J Limburg, Lila J Finney Rutten, A Burak Ozbay, et al.
Inflammatory Bowel Diseases|February 26, 2016
Biological and Immunomodulator Use in Crohn's Disease in a Medicaid PopulationMark H Flasar, Jingdong Chao, A Burak Ozbay, et al.
Clinical and Translational Gastroenterology|June 26, 2025
Adherence to Multitarget Stool DNA Testing in Individuals Aged 45-49 Years With Average Risk for Colorectal CancerMallik Greene, Mark Camardo, A Burak Ozbay, et al.
Current Medical Research and Opinion|October 23, 2025
Completing the colorectal cancer screening process: impact of eliminating cost-sharing for follow-up colonoscopyMallik Greene, Quang A Le, A Burak Ozbay, et al.
Preventive Medicine Reports|February 2, 2022
Life-years gained resulting from screening colonoscopy compared with follow-up colonoscopy after a positive stool-based colorectal screening testA Mark Fendrick, Bijan J Borah, A Burak Ozbay, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Clinical Therapeutics|October 25, 2011
Risk factors for hypoglycemia-related hospitalization in patients with type 2 diabetes: a nested case-control studyBrian J Quilliam, Jason C Simeone, A Burak Ozbay
The American Journal of Managed Care|November 23, 2011
The incidence and costs of hypoglycemia in type 2 diabetesBrian J Quilliam, Jason C Simeone, A Burak Ozbay, et al.
Current Medical Research and Opinion|June 9, 2025
Improving CRC screening in an underserved population: real-world adherence to mt-sDNA testing among the incarcerated in Nebraska, United StatesMallik Greene, Timo Pew, A Burak Ozbay, et al.
The American Journal of Gastroenterology|December 14, 2019
Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare PatientsStuart C Gordon, Jeremy Fraysse, Suying Li, et al.
Current Medical Research and Opinion|March 3, 2025
Adherence to mt-sDNA testing for colorectal cancer screening among new users in a US Black populationMallik Greene, Shrey Gohil, Mark Camardo, et al.
Current Medical Research and Opinion|January 21, 2021
Recent trends in colorectal cancer screening methods based on Medicare claims dataPaul J Limburg, Lila J Finney Rutten, A Burak Ozbay, et al.
Inflammatory Bowel Diseases|February 26, 2016
Biological and Immunomodulator Use in Crohn's Disease in a Medicaid PopulationMark H Flasar, Jingdong Chao, A Burak Ozbay, et al.
Clinical and Translational Gastroenterology|June 26, 2025
Adherence to Multitarget Stool DNA Testing in Individuals Aged 45-49 Years With Average Risk for Colorectal CancerMallik Greene, Mark Camardo, A Burak Ozbay, et al.
Current Medical Research and Opinion|October 23, 2025
Completing the colorectal cancer screening process: impact of eliminating cost-sharing for follow-up colonoscopyMallik Greene, Quang A Le, A Burak Ozbay, et al.
Preventive Medicine Reports|February 2, 2022
Life-years gained resulting from screening colonoscopy compared with follow-up colonoscopy after a positive stool-based colorectal screening testA Mark Fendrick, Bijan J Borah, A Burak Ozbay, et al.
Pageof 6